These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35730631)

  • 1. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.
    Santoro F; Núñez-Gil IJ; Vitale E; Viana-Llamas MC; Romero R; Maroun Eid C; Feltes Guzman G; Becerra-Muñoz VM; Fernández Rozas I; Uribarri A; Alfonso-Rodriguez E; García Aguado M; Huang J; Castro Mejía AF; Garcia Prieto JF; Elola J; Ugo F; Cerrato E; Signes-Costa J; Raposeiras Roubin S; Jativa Mendez JL; Espejo Paeres C; López Masjuan A; Marin F; Guerra F; El-Battrawy I; Cortese B; Ramakrishna H; Perez-Villacastín J; Fernandez-Ortiz A; Brunetti ND
    J Am Heart Assoc; 2022 Jul; 11(13):e024530. PubMed ID: 35730631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
    Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang SY; Price C; Bona RD; Ochoa Chaar CI; Chun HJ; Pine AB; Rinder HM; Siner JM; Neuberg DS; Owusu KA; Lee AI
    Am J Hematol; 2021 Apr; 96(4):471-479. PubMed ID: 33476420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.
    Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang S; Price C; Bona RD; Chaar CIO; Chun HJ; Pine AB; Rinder HM; Siner J; Neuberg DS; Owusu KA; Lee AI
    medRxiv; 2021 Jan; ():. PubMed ID: 33469595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
    Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
    Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
    J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.
    Ionescu F; Jaiyesimi I; Petrescu I; Lawler PR; Castillo E; Munoz-Maldonado Y; Imam Z; Narasimhan M; Abbas AE; Konde A; Nair GB
    Eur J Haematol; 2021 Feb; 106(2):165-174. PubMed ID: 33043484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry.
    Dalbeni A; Susca N; Daidone M; Rossi I; Giontella A; Cimellaro A; Talerico G; Pietrangelo A; Sesti G; Zaccone V; Villani R;
    Intern Emerg Med; 2023 Nov; 18(8):2311-2319. PubMed ID: 37751084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study.
    Mina J; Fleifel M; Haykal T; Dimassi H; Nasr J; Harb R; Mahdi A; El Hout G; Franjieh E; Mokhbat J; Farra A; Husni R
    Medicine (Baltimore); 2023 Jun; 102(25):e34040. PubMed ID: 37352055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort study.
    Spiegelenberg JP; van Gelder MMHJ; Maas ML; Hovens MMC; Esselink A; Dofferhoff ASM; Janssen R; van de Maat J; Janssen N; Blaauw M; Hassing RJ; van Apeldoorn M; Kerckhoffs A; Veerman K; Hoogerwerf J; Kramers C; Leentjens J
    Br J Clin Pharmacol; 2021 Dec; 87(12):4839-4847. PubMed ID: 33899226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching: A Multicenter Retrospective Cohort Study.
    Kaur J; deLongpre J; Koehler T; Laclair H; Bowen M; Khine J; Khosrodad N; Jena N; Dixit P; Yadav S; Mogulla SM; Coakley R; Sule A; Krishnamoorthy G
    Am J Ther; 2021 Nov; 29(1):e43-e49. PubMed ID: 34994348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.
    Denas G; Gennaro N; Ferroni E; Fedeli U; Lorenzoni G; Gregori D; Iliceto S; Pengo V
    Int J Cardiol; 2021 Apr; 329():266-269. PubMed ID: 33309764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits.
    Yu B; Gutierrez VP; Carlos A; Hoge G; Pillai A; Kelly JD; Menon V
    Biomark Res; 2021 May; 9(1):29. PubMed ID: 33933168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis.
    Chow JH; Yin Y; Yamane DP; Davison D; Keneally RJ; Hawkins K; Parr KG; Al-Mashat M; Berger JS; Bushardt RL; Mazzeffi MA; Nelson SJ
    J Thromb Haemost; 2021 Nov; 19(11):2814-2824. PubMed ID: 34455688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).
    Santoro F; Núñez-Gil IJ; Viana-Llamas MC; Maroun Eid C; Romero R; Fernández Rozas I; Aparisi A; Becerra-Muñoz VM; García Aguado M; Huang J; Maltese L; Cerrato E; Alfonso-Rodriguez E; Castro Mejía AF; Marin F; Raposeiras Roubin S; Pepe M; Moreno Munguia VH; Feltes G; Navas JV; Cortese B; Buzón L; Liebetrau C; Ramos-Martinez R; Fernandez-Ortiz A; Estrada V; Brunetti ND
    Crit Care Med; 2021 Jun; 49(6):e624-e633. PubMed ID: 33861553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality of hospitalized patients with COVID-19: Effects of treatment options (vitamin D, anticoagulation, isoprinosine, ivermectin) assessed by propensity score matching, retrospective analysis.
    Plasek J; Dodulik J; Gai P; Hrstkova B; Skrha J; Zlatohlavek L; Vlasakova R; Danko P; Ondracek P; Cubova E; Capek B; Kollarova M; Furst T; Vaclavik J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):35-43. PubMed ID: 38050692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
    Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is oral anticoagulation effective in preventing transcatheter aortic valve implantation failure? A propensity matched analysis of the Italian Transcatheter balloon-Expandable valve Registry study.
    Conrotto F; D'Ascenzo F; Bianco M; Salizzoni S; D'Onofrio A; Ribichini F; Tarantini G; D'Amico M; Moretti C; Rinaldi M;
    J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):51-57. PubMed ID: 31869314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.